Targeted Therapy Leads 2012 Cancer Advances
(MedPage Today) — Targeted therapies for metastatic HER2-positive breast cancer are among this year’s top advances in oncology, according to the American Society of Clinical Oncology.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com